Israeli AI companies in biopharma R&D are not leaving Israel
Israel is justified in its concerns over whether scientific, technological and economic value created by artificial intelligence companies in biopharma research and development will remain in the country as those companies develop and grow.Many such companies start with employees concentrated in Israel. Later, a share of their workforce and senior leadership may be based in the United States. As this trend gains momentum, it eventually means that the company leaves Israel.But that’s only half the story.Three key questions linger: What changes as these companies’ AI models and platforms mature? Why do they need clinical, product, leadership and commercial capabilities in the United States? And why can that evolution ultimately create more value for Israel rather than less?Many Israeli AI companies in biopharma R&D begin with Israeli founders, machine learning specialists, data scientists and engineers. For the platform to mature into a viable product, however, the company must evolve. It needs…
Israeli AI companies in biopharma R&D often expand their operations to the United States, a trend that, while appearing to diminish their Israeli presence, actually enhances their overall value and viability. Initially, these companies concentrate their machine learning specialists and engineers in Israel. However, to mature into commercially viable products, they must acquire clinical, product, leadership, and commercial expertise, much of which is concentrated in the U.S. due to the talent pool and market.
The U.S. organization complements the Israeli base rather than replacing it.
This expansion allows Israeli AI companies to gain crucial industry knowledge and access to customers, partners, and investment, which in turn feeds resources back into their Israeli R&D. The author argues that the true measure of success is whether the company acquires necessary capabilities to compete while continuing to create scientific, technological, and economic value in Israel, making the U.S. expansion a process through which Israel ultimately benefits.
© All rights to the original article belong to the source. Din Online shows a headline, an excerpt and a link only. The objectivity rating is computed automatically and is an estimate only.
Discussion
No comments yet — be the first to comment.